SKI Market

Indian Indices

Nifty

26,186.45 152.70
(0.59%)

Sensex

85,102.69 -609.68
( -0.71%)

Bank Nifty

59,777.20 488.50
( 0.82%)

Nifty IT

38,703.65 343.40
( 0.90%)

Global Indices

Nasdaq

47,981.01 109.07
(0.23%)

Dow Jones

6,892.33 14.21
(0.21%)

Hang Seng

50,472.24 -19.63
(-0.04%)

Nikkei 225

9,667.01 -43.86
(-0.45%)

Forex

USD-INR

89.99 -0.14
(-0.16%)

EUR-INR

104.92 -0.11
(-0.11%)

GBP-INR

120.05 0.29
(0.24%)

JPY-INR

0.58 0.00
(0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivanza Biosciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

530057

INE984E01035

1.12525

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

8.8

EPS(TTM)

Face Value()

Div & Yield %

Back

starlineps enterprises ltd

The Ramco Cements consolidated net profit rises 200.93% in the September 2025 quarter

Nov 06,2025

Net profit of The Ramco Cements rose 200.93% to Rs 77.34 crore in the quarter ended September 2025 as against Rs 25.70 crore during the previous quarter ended September 2024. Sales rose 9.52% to Rs 2238.74 crore in the quarter ended September 2025 as against Rs 2044.13 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2238.74	2044.13	10
OPM %	17.33	15.36	-
PBDT	283.17	204.02	39
PBT	99.83	34.49	189
NP	77.34	25.70	201

26,186.45 152.70 (0.59%)

85,102.69 -609.68 ( -0.71%)

59,777.20 488.50 ( 0.82%)

38,703.65 343.40 ( 0.90%)

47,981.01 109.07 (0.23%)

6,892.33 14.21 (0.21%)

50,472.24 -19.63 (-0.04%)

9,667.01 -43.86 (-0.45%)

89.99 -0.14 (-0.16%)

104.92 -0.11 (-0.11%)

120.05 0.29 (0.24%)

0.58 0.00 (0.11%)